Physician profile
Barry E Levant
NPI 1760456016
$503.95
in general payments reported to CMS, 2019-2025
16 companies · $59.37 in 2025
The $59.37 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $27.44 · 2021: $37.68 · 2022: $37.09 · 2023: $134 · 2024: $58.98 · 2025: $59.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $103.20 | 2023-2025 | Farxiga, Breztri |
| Astellas Pharma US INC | $42.07 | 2019 | |
| Allergan, INC. | $40.93 | 2019-2020 | |
| Pfizer INC. | $38.64 | 2019-2021 | |
| Abbott Laboratories | $34.74 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $34.34 | 2023 | Repatha, Otezla |
| Amarin Pharma, INC. | $30.00 | 2019-2021 | |
| Glaxosmithkline, LLC. | $29.80 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $27.70 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $25.56 | 2019 | |
| Althera Pharmaceuticals LLC | $22.44 | 2021-2022 | |
| Exact Sciences Corporation | $18.22 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $17.16 | 2024 | Mounjaro |
| Cashflow Solutions, LLC | $14.53 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| E.R. Squibb & Sons, L.L.C. | $12.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Levant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.